CalciMedica(CALC) - 2024 Q1 - Quarterly Report

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts): | --- | --- | --- | |--------------------------------------------------|--------------------------|------------| | | As of March \n2024 | 31, \n2023 | | Stock options to purchase common stock | 1,818,314 | 1,230,173 | | Warrants to purchase common stock | 5,644,300 | 276,437 | | Total | 7,462,614 | 1,506,610 | Overview The Merger was accounted for as a reverse recapitaliz ...